{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:27:35Z","timestamp":1776868055760,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.medcli.2012.02.026","type":"journal-article","created":{"date-parts":[[2012,9,14]],"date-time":"2012-09-14T05:19:28Z","timestamp":1347599968000},"page":"351-355","source":"Crossref","is-referenced-by-count":6,"title":["Factores predictivos de reversi\u00f3n a ritmo sinusal precardioversi\u00f3n el\u00e9ctrica en pacientes con fibrilaci\u00f3n auricular persistente tratados con antiarr\u00edtmicos"],"prefix":"10.1016","volume":"140","author":[{"given":"Xavier","family":"Vi\u00f1olas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"Romero-Menor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep M.","family":"Alegret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2012.02.026_bib0005","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-9149(89)90574-2","article-title":"Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter","volume":"64","author":"Van Gelder","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0010","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1001\/jama.1992.03480240051033","article-title":"Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter","volume":"267","author":"Gosselink","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2012.02.026_bib0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(96)00779-5","article-title":"Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators","volume":"79","author":"Stroobandt","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2012.02.026_bib0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ehj.2003.10.020","article-title":"A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation","volume":"25","author":"Channer","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2012.02.026_bib0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/hrt.2003.022665","article-title":"A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation","volume":"90","author":"Boos","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2012.02.026_bib0035","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2012.02.026_bib0040","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0300-8932(08)75735-X","article-title":"Utilidad en la pr\u00e1ctica cl\u00ednica del tratamiento antiarr\u00edtmico tras cardioversi\u00f3n el\u00e9ctrica en pacientes sin cardiopat\u00eda structural","volume":"61","author":"Alegret","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.medcli.2011.02.025","article-title":"El tratamiento de la fibrilaci\u00f3n auricular: \u00bfuna cuesti\u00f3n de perspectiva?","volume":"137","author":"De Diego Rus","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2012.02.026_bib0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0002-9149(93)91015-A","article-title":"Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function","volume":"71","author":"Suttorp","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0055","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation de la European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2012.02.026_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.medcli.2010.09.007","article-title":"Uso e implicaciones cl\u00ednicas del mantenimiento del tratamiento anticoagulante tras una cardioversi\u00f3n exitosa","volume":"137","author":"Alegret","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2012.02.026_bib0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/hrt.2008.155812","article-title":"Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs","volume":"96","author":"Schilling","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.medcli.2012.02.026_bib0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0735-1097(96)00230-6","article-title":"Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study","volume":"28","author":"Bianconi","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00063110-199812000-00008","article-title":"Predictors of success in the conversion of new-onset atrial fibrillation using oral propafenone","volume":"5","author":"Ergene","year":"1998","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.medcli.2012.02.026_bib0080","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","article-title":"Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset","volume":"25","author":"Reisinger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2012.02.026_bib0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2005.09.009","article-title":"A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned","volume":"151","author":"Vijayalakshmi","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.medcli.2012.02.026_bib0090","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.CIR.82.3.792","article-title":"Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study","volume":"82","author":"Sanfilippo","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2012.02.026_bib0095","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1001\/archinte.166.21.2322","article-title":"Risk of new-onset atrial fibrillation in relation to body mass index","volume":"166","author":"Dublin","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2012.02.026_bib0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.amjcard.2010.10.018","article-title":"Relation of obesity to recurrence rate and burden of atrial fibrillation","volume":"107","author":"Guglin","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0105","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/europace\/eum107","article-title":"Predictors of success and effect of biphasic energy on electrical cardioversion in patients with persistent atrial fibrillation","volume":"9","author":"Alegret","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.medcli.2012.02.026_bib0110","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/eurheartj\/ehp091","article-title":"Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery","volume":"30","author":"Girerd","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2012.02.026_bib0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/HCO.0b013e328341398e","article-title":"The role of obesity and sleep apnea in atrial fibrillation","volume":"26","author":"Needleman","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0120","article-title":"Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation","author":"Dimitri","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.medcli.2012.02.026_bib0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.carpath.2007.12.003","article-title":"Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation","volume":"17","author":"Knackstedt","year":"2008","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.medcli.2012.02.026_bib0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/CIRCEP.109.924985","article-title":"Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease","volume":"3","author":"Mayyas","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312005970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775312005970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T20:56:41Z","timestamp":1542747401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775312005970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0025775312005970"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2012.02.026","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}